Mei‐Ling Cheng

6.7k total citations
229 papers, 5.0k citations indexed

About

Mei‐Ling Cheng is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Mei‐Ling Cheng has authored 229 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 44 papers in Physiology and 29 papers in Epidemiology. Recurrent topics in Mei‐Ling Cheng's work include Metabolomics and Mass Spectrometry Studies (32 papers), Neonatal Health and Biochemistry (16 papers) and Liver Disease Diagnosis and Treatment (11 papers). Mei‐Ling Cheng is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (32 papers), Neonatal Health and Biochemistry (16 papers) and Liver Disease Diagnosis and Treatment (11 papers). Mei‐Ling Cheng collaborates with scholars based in Taiwan, China and United States. Mei‐Ling Cheng's co-authors include Hung‐Yao Ho, Daniel T. Chiu, Chiung‐Mei Chen, Ming‐Shi Shiao, Hsiang-Yu Tang, Chao‐Hung Wang, Yih‐Ru Wu, Cheng-Yu Huang, Gigin Lin and Min‐Hui Liu and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Mei‐Ling Cheng

206 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei‐Ling Cheng Taiwan 39 2.3k 878 538 497 449 229 5.0k
Gerry R. Boss United States 51 4.1k 1.8× 1.1k 1.2× 434 0.8× 557 1.1× 401 0.9× 216 8.1k
Richard Siow United Kingdom 41 2.3k 1.0× 606 0.7× 294 0.5× 351 0.7× 268 0.6× 102 4.7k
Thozhukat Sathyapalan United Kingdom 47 2.0k 0.9× 899 1.0× 647 1.2× 503 1.0× 484 1.1× 380 8.1k
Diane E. Handy United States 47 3.9k 1.7× 1.3k 1.5× 446 0.8× 680 1.4× 759 1.7× 89 8.5k
Alex Odermatt Switzerland 53 3.5k 1.5× 572 0.7× 404 0.8× 206 0.4× 497 1.1× 241 9.3k
Young‐Mi Go United States 48 4.3k 1.8× 1.3k 1.5× 436 0.8× 329 0.7× 268 0.6× 143 8.0k
Scott W. Ballinger United States 43 5.1k 2.2× 1.4k 1.6× 693 1.3× 454 0.9× 477 1.1× 97 8.2k
Akira Honda Japan 43 3.6k 1.6× 852 1.0× 814 1.5× 330 0.7× 262 0.6× 270 7.6k
Gunnar Mellgren Norway 38 2.2k 0.9× 1.3k 1.5× 619 1.2× 431 0.9× 338 0.8× 164 5.2k
Éric Fontaine France 40 4.5k 1.9× 1.4k 1.7× 601 1.1× 484 1.0× 241 0.5× 179 7.2k

Countries citing papers authored by Mei‐Ling Cheng

Since Specialization
Citations

This map shows the geographic impact of Mei‐Ling Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Ling Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Ling Cheng more than expected).

Fields of papers citing papers by Mei‐Ling Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Ling Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Ling Cheng. The network helps show where Mei‐Ling Cheng may publish in the future.

Co-authorship network of co-authors of Mei‐Ling Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Ling Cheng. A scholar is included among the top collaborators of Mei‐Ling Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Ling Cheng. Mei‐Ling Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chou, Yi-Ju, Chi‐Hsiao Yeh, Chian‐Feng Chen, et al.. (2025). Activation of CISD2 as a protective strategy against doxorubicin-induced cardiotoxicity. Redox Biology. 86. 103840–103840.
2.
Wu, I‐Wen, Yu-Chieh Liao, Tsung-Hsien Tsai, et al.. (2025). Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease. Gut Microbes. 17(1). 2473506–2473506. 8 indexed citations
3.
Tsai, Chung‐Ying, Cheng-Lung Hsu, Tzong-Shyuan Tai, et al.. (2025). Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations. Nature Metabolism. 7(5). 918–927. 9 indexed citations
4.
Lei, Haike, et al.. (2025). Global burden of vertebral fractures from 1990 to 2021 and projections for the next three decades. Journal of Orthopaedic Surgery and Research. 20(1). 480–480. 2 indexed citations
5.
Tsai, Chi‐Neu, et al.. (2025). NRF2-SOX4 complex regulates PSPH in hepatocellular carcinoma and modulates M2 macrophage differentiation. Cancer Gene Therapy. 32(11). 1218–1232. 2 indexed citations
6.
7.
Tang, Hsiang-Yu, et al.. (2024). MRMQuant: Automated MRM Data Quantitation for Large-Scale Targeted Metabolomics Analysis. Analytical Chemistry. 96(33). 13625–13635. 3 indexed citations
8.
Lee, Chao‐Wei, Hsin‐I Tsai, Ming‐Chin Yu, et al.. (2024). Do low skeletal muscle bulk and disturbed body fat mass impact tumor recurrence in stage I/II hepatocellular carcinoma undergoing surgery? An observational cohort study. International Journal of Surgery. 110(11). 7067–7079. 2 indexed citations
9.
Cheng, Mei‐Ling, Yunching Chen, Chi-Jen Lo, et al.. (2024). Helicobacter pylori PldA modulates TNFR1-mediated p38 signaling pathways to regulate macrophage responses for its survival. Gut Microbes. 16(1). 2409924–2409924. 4 indexed citations
10.
Cheng, Mei‐Ling, et al.. (2024). (Co, S)-Codoped BiOBr as a novel signal probe coupled with LAMP (H+)-pH responsive photoelectrochemistry biosensor for ultrasensitive detection of microRNA. Sensors and Actuators B Chemical. 422. 136482–136482. 5 indexed citations
11.
Tang, Hsiang-Yu, et al.. (2023). Metabolomics Assessment of Volume Overload-Induced Heart Failure and Oxidative Stress in the Kidney. Metabolites. 13(11). 1165–1165. 4 indexed citations
12.
Cheng, Mei‐Ling, et al.. (2023). Malonyl-CoA Accumulation as a Compensatory Cytoprotective Mechanism in Cardiac Cells in Response to 7-Ketocholesterol-Induced Growth Retardation. International Journal of Molecular Sciences. 24(5). 4418–4418. 7 indexed citations
13.
Chang, Kuo‐Hsuan, Mei‐Ling Cheng, Hsiang-Yu Tang, et al.. (2022). Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease. Cells. 11(3). 395–395. 27 indexed citations
14.
Lin, Huan-Tang, Mei‐Ling Cheng, Chi-Jen Lo, Gigin Lin, & Fu-Chao Liu. (2022). Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry. Diagnostics. 12(11). 2626–2626. 6 indexed citations
15.
Kuo, Wen‐Ling, Che‐Chang Chang, Chih‐Jung Chen, et al.. (2021). Prognostic Significance of O-GlcNAc and PKM2 in Hormone Receptor-Positive and HER2-Nonenriched Breast Cancer. Diagnostics. 11(8). 1460–1460. 7 indexed citations
16.
Chiu, Chih‐Yung, Mei‐Ling Cheng, Meng‐Han Chiang, et al.. (2019). Gut microbial‐derived butyrate is inversely associated with IgE responses to allergens in childhood asthma. Pediatric Allergy and Immunology. 30(7). 689–697. 71 indexed citations
17.
Tang, Hsiang-Yu, Hung‐Yao Ho, Daniel T. Chiu, et al.. (2017). Alterations of plasma concentrations of lipophilic antioxidants are associated with Guillain-Barre syndrome. Clinica Chimica Acta. 470. 75–80. 10 indexed citations
18.
Leu, Yann-Lii, Mei‐Ling Cheng, Ching-Chuan Liu, et al.. (2017). Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid. Scientific Reports. 7(1). 12264–12264. 32 indexed citations
19.
20.
Cheng, Mei‐Ling. (2006). Extreme Performance and Installation from China. 88.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerry R. Boss Breakdown of academic impact, for papers by Richard Siow Breakdown of academic impact, for papers by Thozhukat Sathyapalan Breakdown of academic impact, for papers by Diane E. Handy Breakdown of academic impact, for papers by Alex Odermatt Breakdown of academic impact, for papers by Young‐Mi Go Breakdown of academic impact, for papers by Scott W. Ballinger Breakdown of academic impact, for papers by Akira Honda Breakdown of academic impact, for papers by Gunnar Mellgren Breakdown of academic impact, for papers by Éric Fontaine
Rankless by CCL
2026